Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial

Introduction Septic shock is the subgroup of patients with sepsis, which presents as vasopressor dependence, an elevated blood lactate concentration and is associated with a mortality of at least 30%. Expression of the triggering receptor expressed on myeloid cells 1 (TREM-1) pathway, measured using...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Pierre-François Laterre, Stephan Witte, Jean-Marie Grouin, Simon Lambden, Bruno Francois, Sebastien Gibot, Marc Derive, Aurelie Olivier, Valerie Cuvier, Jean Jacques Garaud, Margarita Salcedo-Magguilli, Mitchell Levy
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2021-07-01
coleção:	BMJ Open
Acesso em linha:	https://bmjopen.bmj.com/content/11/7/e042921.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!